Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2024 ∙ Grant, L. R. Hanquet, G. Sepulveda-Pachon, I. T. Theilacker, C. Baay, M. Slack, M. P. E. Jodar, L. Gessner, B. D.

Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Wagner, G. Gartlehner, G. Thaler, K. Ledinger, D. Feyertag, J. Klerings, I. Saif-Ur-Rahman, K. M. Devane, D. Olsson, K. Adel Ali, K. Vygen-Bonnet, S. Salo, H. Zavadska, D. Grgic Vitek, M. Oona, M. Cunney, R. Tuerlinckx, D. Kristensen Lomholt, F. Sommer, I.

Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2024 ∙ Feng, S. McLellan, J. Pidduck, N. Roberts, N. Higgins, J. P. Choi, Y. Izu, A. Jit, M. Madhi, S. A. Mulholland, K. Pollard, A. J. Procter, S. Temple, B. Voysey, M.

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Beetch, J. E. Janitz, A. Beebe, L. A. Gowin, M. Xu, C. Clifton, S. Kuhn, K. G.

Indirect Effects of the COVID-19 Pandemic on Routine Childhood Vaccination in Low-Income Countries: A Systematic Review to Set the Scope for Future Pandemics

  • Newborn
  • Children
  • Adolescents
  • Low and Middle Income Countries
  • Tuberculosis
  • Poliomyelitis
  • Diphtheria
  • Pertussis
  • Tetanus
  • Hepatitis B
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Rotavirus
  • Measles
  • Rubella
  • Malaria
  • Yellow fever
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Besteman, S. B. Bogaert, D. Bont, L. Mejias, A. Ramilo, O. Weinberger, D. M. Dagan, R.

Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Bardach, A. Ruvinsky, S. Palermo, M. C. Alconada, T. Sandoval, M. M. Brizuela, M. E. Wierzbicki, E. R. Cantos, J. Gagetti, P. Ciapponi, A.

Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis

  • Americas
  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Papagiannis, D. Kourek, C. Briasoulis, A. Fradelos, E. C. Papagianni, E. D. Papadimopoulos, I. Giamouzis, G. Skoularigis, J. Xanthopoulos, A.

Pneumococcal and Influenza Vaccination Coverage in Patients with Heart Failure: A Systematic Review

  • All age groups
  • Pneumococcal disease
  • Influenza
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Santangelo, O. E. Provenzano, S. Vella, C. Fermi, S. Facchini, L. Rizzo, M. Brighina, F. Cedrone, F. Firenze, A.

Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review

  • All age groups
  • COVID-19
  • Influenza
  • Measles
  • Mumps
  • Rubella
  • Yellow fever
  • Varicella
  • Tetanus
  • Tick-borne encephalitis
  • Diphtheria
  • Pertussis
  • Meningococcal disease
  • Pneumococcal disease
  • Rabies
  • Haemophilus influenzae type B
  • Hepatitis B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Du, P. Jin, S. Lu, S. Wang, L. Ma, X. Wang, J. Huang, R. Luo, Q. Yang, S. Feng, X.

Strategies to increase the coverage of influenza and pneumonia vaccination in older adults: a systematic review and network meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Price, O. Swanton, R. Grebely, J. Hajarizadeh, B. Webb, P. Peacock, A. Dore, G. J. Cowie, B. C. Vickerman, P. Degenhardt, L.

Vaccination coverage among people who inject drugs: A systematic review

  • All age groups
  • COVID-19
  • Hepatitis A
  • Hepatitis B
  • Human papillomavirus (HPV)
  • Influenza
  • Pneumococcal disease
  • Tetanus
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...